Keyphrases
Histone Deacetylase Inhibitor (HDACi)
100%
Chronic Kidney Disease
89%
AN-7
89%
Myocardial Infarction
84%
Prodrug
78%
Cardiorenal Syndrome
76%
AN-9
76%
Acute Myocardial Infarction
74%
Rat Model
73%
Reverse Transcriptase
67%
Regulatory T Cells
67%
Butyric Acid
59%
Treg
56%
Antineoplastic Agents
55%
Cardiac Cells
53%
Macrophages
53%
Cardiac Remodeling
49%
Diethyl Phosphite
47%
Transient Receptor Potential Vanilloid 2
46%
Echocardiography
46%
TRPV2
44%
Chronic Volume Overload
44%
Matrix metalloproteinase-9 (MMP-9)
44%
Cation Channel
44%
Mouse Mammary Tumor Virus
44%
Hindlimb Ischemia
44%
Islet1
44%
Blocking Antibodies
44%
Anti-metastatic Activity
44%
Retinal pigment Epithelium
44%
Cardiac Hypertrophy
42%
Cardiac Function
41%
Glioma
39%
Serum Levels
38%
Regulatory T (Treg) Cells
36%
Cardiomyocytes
33%
Confidence Interval
32%
Cell Viability
31%
Eotaxin-2
31%
Peri-infarct
30%
In Vivo Efficacy
29%
Glioma Cell Lines
29%
Anticancer Activity
28%
Apoptosis
28%
Cardiac Fibrosis
28%
Cellular Level
28%
Malignant Glioma
28%
Radiosensitization
28%
Endothelial Cells
27%
DNA Synthesis
26%
Medicine and Dentistry
Antineoplastic Activity
97%
Histone Deacetylase Inhibitor
93%
Chronic Kidney Disease
89%
Prodrug
88%
Cardiorenal Syndrome
78%
Infarction
69%
Myocardial Infarction
58%
Butyric Acid
58%
Regulatory T Cell
56%
Glioblastoma
56%
Cardiac Muscle Cell
51%
Neoplasm
48%
Echocardiography
48%
In Vitro
45%
Vanilloid Receptor 2
44%
Macrophage
44%
Metastasis Inhibition
44%
Ganglioglioma
43%
Heart Function
39%
Heart Ventricle Remodeling
39%
Mesenchymal Stem Cell
35%
Glioma Cell Line
33%
Acute Heart Infarction
30%
Cardiac Fibrosis
30%
Pivaloyloxymethyl Butyrate
29%
Tumor Progression
28%
Endothelial Cell
26%
Metabolite
26%
Gene Targeting
25%
Hemodynamic
25%
Mitochondrion
25%
Ventricular Hypertrophy
24%
Surgery
24%
Programmed Cell Death
23%
Cardiac Physiology
22%
TRPV2
22%
Heart Failure
22%
Neutrophil Gelatinase Associated Lipocalin
22%
Phosphoinositide 3-Kinase
22%
Ischemia
22%
Cardiac Pathology
22%
Phosphoinositide 3-Kinase Inhibitor
22%
Adoptive Transfer
22%
Gelatinase B
22%
Adipose Tissue
22%
Sodium Phenylbutyrate
22%
Cell Proliferation
22%
Blood Stasis
22%
Blood Flow
22%
Downregulation
22%
Pharmacology, Toxicology and Pharmaceutical Science
Prodrug
91%
Chronic Kidney Failure
89%
Mouse
82%
Heart Infarction
80%
Cardiorenal Syndrome
78%
Rat Model
73%
Histone Deacetylase Inhibitor
71%
Infarction
67%
Butyrate
61%
Glioblastoma
48%
Neoplasm
48%
Visual Pigment
44%
RNA Directed DNA Polymerase
44%
Acute Heart Infarction
43%
Vasculotropin
41%
Heart Ventricle Remodeling
39%
Anticarcinogen
33%
Inflammation
32%
Heart Ventricle Hypertrophy
30%
Metastasis Inhibition
29%
Heart Failure
28%
Heart Muscle Fibrosis
25%
Fibrosis
24%
Cell Viability
24%
Renin
22%
Ranibizumab
22%
Doxorubicin
22%
Sodium Phenylbutyrate
22%
Apolipoprotein E Knockout Mouse
22%
Blood Stasis
22%
All Cause Mortality
22%
Neutrophil Gelatinase Associated Lipocalin
22%
Carditis
22%
Antiangiogenic
22%
Gelatinase B
22%
Cardiomyopathy
22%
Proteinase
22%
Bovine Leukemia Virus
22%
Calcitriol
22%
Kidney Fibrosis
22%
Erythropoietin Receptor
22%
Phosphatidylinositol 3 Kinase Inhibitor
22%
Gene Delivery
22%
Blocking Antibody
22%
Atherosclerosis
22%
Vitamin D Receptor
22%
Knockout Mouse
22%
Cytokine
22%
Experimental Myocardial Infarction
22%
Erythropoietin
22%